The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?”was just published in the journalActa Poloniae Pharmaceutica – Drug Research…
Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.
Indeed, Ivermectin in concert with Mebendazole has shown amazing promise in treating a wide variety of cancers.
Mebendazole, an anti-parasitic like Ivermectin, has been prescribed for 100 years to help eradicate parasites – which over 60 million Americans have inside their body today, according to the CDC.
Experts like Dr. William Makis have been touting early research that points to Ivermectin and Mebendazole being potent treatments for cancer.
